Previous Close | 0.2073 |
Open | 0.2110 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.2050 - 0.2110 |
52 Week Range | 0.1447 - 0.4315 |
Volume | |
Avg. Volume | 90,983 |
Market Cap | 16.909M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | 2.56 |
EPS (TTM) | 0.0800 |
Earnings Date | Aug 22, 2023 - Aug 28, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Revenue of $9.1 million, Adjusted EBITDA of $2.9 million, Adjusted EBITDA Margin of 32%.Generated positive EBITDA of $1.6 million.Expanded retail footprint through the acquisition of Jackson, Ohio dispensary and reported solid performance during first quarter under Vext ownership. Previously announced acquisition of vertically integrated Ohio operations on track to close towards the end of Q3 2023 and expected to bring continued growth for Vext in 2023.Vancouver, British Columbia--(Newsfile Corp
Vancouver, British Columbia--(Newsfile Corp. - May 15, 2023) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio1, today announced that it plans to release its financial results for the first quarter ended March 31, 2023, before market open on May 25, 2023.The Company will also host a conference call and webcast on Thursday, May 25, 2023 at 8:00 a.m. ET to ...
Vancouver, British Columbia--(Newsfile Corp. - April 5, 2023) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator with vertical operations in Arizona and Ohio1, announced today that it will be participating in two upcoming conferences:Benzinga Cannabis Capital Conference, between April 11 and 12, 2023. Vext's CEO Eric Offenberger will participate in a panel "Bigger Isn't Always Better: Operators Poised for Success" on the Playbook Stage at 11:
Demonstrates ability to drive consistent operating performance even against a challenging consumer backdrop - 2022 Revenue of $35.4 million; Adjusted EBITDA of $15.1 million (+12.8% vs. 2021).Q4 Revenue and Adjusted EBITDA of $8.2 million and $3.2 million, respectively.2023 expected to bring significant growth for Vext, as results derived from the recent announcement of its acquisition of vertically integrated Ohio operations are consolidated into its financial results1.Vancouver, British Columb
Vancouver, British Columbia--(Newsfile Corp. - March 6, 2023) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio1, today announced that it plans to release its financial results for the period ended December 31, 2022 before market open on March 22, 2023.The Company will also host a conference call and webcast on Wednesday, March 22, 2023 at 8:00 a.m. ET to discuss ...
Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.comNEW YORK, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, in partnership with KCSA Strategic Communications (“KCSA”), today announced the presentations from the KCSA Cannabis Virtual Investor Conference held on February 23rd are now available for online viewing. REGISTER NOW AT: https://tinyurl.com/0223cannabisvic The company presentations will
Product expected to be 100% absorbed within Vext's retail network, contributing to a lower cost base Vancouver, British Columbia--(Newsfile Corp. - February 23, 2023) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator with vertical operations in Arizona and Ohio1, today announced that it has been granted a Certificate of Occupancy by the City of Eloy for its 17,000 square foot cultivation space in Eloy (the "Facility"). The Company ...
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, in partnership with KCSA Strategic Communications (“KCSA”), today announced the agenda for the KCSA Cannabis Virtual Investor Conference to be held February 23rd. Individual investors, institutional investors, advisors, and analysts are invited to attend. REGISTER NOW AT: http://bit
Ohio expected to be one of the most attractive market opportunities in U.S. cannabis - Vext has been scaling operations to grow its footprint in the state Vancouver, British Columbia--(Newsfile Corp. - February 21, 2023) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator with vertical operations in Arizona and Ohio1, today announced that an affiliated entity (the "Affiliate") of the Company's joint venture partner, Appalachian Pharm Processin
Vext Science, Inc. ("Vext" or the "Company") (CSE: VEXT) (OTCQX: VEXTF) a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation and marketing to build a profitable multi-state footprint, announces that shareholders voted in favour of all matters included in the Company's information circular for its Annual General Meeting of Shareholders held on December 15, 2022 in Vancouver, British Columbia (the "Meeting").
Vext Science, Inc. ("Vext" or the "Company") (CSE: VEXT) (OTCQX: VEXTF) a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation and marketing to build a profitable multi-state footprint, today announced that it has entered into definitive agreements (the "Purchase Agreements") to acquire Appalachian Pharm Processing, LLC, an Ohio limited liability company, together with its subsidiaries and affiliated companies (collectively, "APP") fo
Vext Science, Inc. ("VEXT" or the "Company") (OTCQX: VEXTF) (CSE: VEXT) a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation, and marketing to build a profitable multi-state footprint, today reported its financial results for the period ended September 30, 2022. All currency references used in this news release are in U.S. currency unless otherwise noted.
Vext Science, Inc. ("Vext" or the "Company") (CSE: VEXT) (OTCQX: VEXTF), a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation and marketing to build a profitable multi-state footprint, announced today that it plans to release its financial results for the third quarter ended September 30, 2022, before market open on November 17, 2022.
Vext Science, Inc. ("Vext" or the "Company") (CSE: VEXT) (OTCQX: VEXTF), a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation, and marketing to build a profitable multi-state footprint, announces the refinancing (the "Refinancing") of the Company's existing US$4,400,000 principal amount of 10% secured non-convertible debentures (the "Existing Debentures") issued by the Company on December 31, 2019 and maturing December 31, 2022.
Vext Science, Inc. ("Vext" or the "Company") (CSE: VEXT) (OTCQX: VEXTF) a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation and marketing to build a profitable multi-state footprint, today announced that an affiliated entity (the "Affiliate") of the Company's joint venture partner, Appalachian Pharm Processing, LLC, an Ohio limited liability company ("APP") has passed state inspection and been granted a Certificate of Operation by
Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation, and marketing to build a profitable multi-state footprint, announced today that it has granted an aggregate of 1,250,000 stock options ("Options") and 3,000,000 restricted share units ("RSUs") to certain directors and officers of the Company, including 1,000,000 Options and 3,000,000 RSUs to Eric Offenberger
Vext Science, Inc. ("VEXT" or the "Company") (OTCQX: VEXTF) (CSE: VEXT) a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation and marketing to build a profitable multi-state footprint, today reported its financial results for the period ended June 30, 2022. All currency references used in this news release are in U.S. currency unless otherwise noted.
Vext Science, Inc. ("Vext" or the "Company") (CSE: VEXT) (OTCQX: VEXTF), a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation and marketing to build a profitable multi-state footprint, announced today that it plans to release its financial results for the second quarter ended June 30, 2022, after market close on August 24, 2022.
Vext Science, Inc. ("Vext" or the "Company") (CSE: VEXT) (OTCQX: VEXTF) a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation and marketing to build a profitable multi-state footprint, today announced that it has entered into an agreement with a California-based lender for a $22.2 million credit facility (the "Credit Facility"), which will be used to refinance current secured debt, and working capital for potential acquisitions, capi
Vext Science, Inc. ("Vext" or the "Company") (CSE: VEXT) (OTCQX: VEXTF) a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation and marketing to build a profitable multi-state footprint, today announced that the Company has changed its auditor from Harbourside CPA LLP ("Harbourside" or the "Former Auditor") to BF Borgers CPA PC (the "Successor Auditor") effective immediately, until the close of the Company's next Annual General Meeting
Vext Science, Inc. ("Vext" or the "Company") (CSE: VEXT) (OTCQX: VEXTF) a cannabinoid brand leader based in Arizona, leveraging its core expertise in extraction, manufacturing, cultivation and marketing to build a profitable multi-state footprint, today announced that current Chief Financial Officer Daniel Engel, has decided to leave the Company to pursue an opportunity with a private equity backed company. Stephan Bankosz will take over as Vext's interim CFO and Corporate Secretary while the Co